Supplementary Figures and Tables from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma | Synapse
March 4, 2024Open Access
Supplementary Figures and Tables from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
Key Points
Key points are not available for this paper at this time.